Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1985-04-09
1986-11-25
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514227, 514255, 514340, 514422, A61K 3140, A61K 31445, A61K 31495, A61K 31535
Patent
active
046249630
ABSTRACT:
Oxindole compounds of the formula I ##STR1## in which R.sup.1, R.sup.2, R.sup.3, R.sup.1', R.sup.2', R.sup.3', R.sup.4, R.sup.5 and R.sup.6 have the meanings given, and physiologically acceptable salts thereof, for the treatment of epilepsy and their use for the preparation of a medicament for the treatment of epilepsy are described.
REFERENCES:
patent: 4542148 (1985-09-01), Kuch et al.
Kruse Hansjorg
Kuch Heinz
Hoechst Aktiengesellschaft
Raymond Richard L.
Springer D. B.
LandOfFree
Use of oxindole compounds for the treatment of epilepsy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of oxindole compounds for the treatment of epilepsy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of oxindole compounds for the treatment of epilepsy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1158715